[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Pulmonx Corp (LUNG)

Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 102,216
  • Shares Outstanding, K 42,948
  • Annual Sales, $ 90,500 K
  • Annual Income, $ -54,000 K
  • EBIT $ -46 M
  • EBITDA $ -46 M
  • 60-Month Beta 0.28
  • Price/Sales 1.15
  • Price/Cash Flow N/A
  • Price/Book 2.61

Options Overview Details

View History
  • Implied Volatility 120.37% (-4.33%)
  • Historical Volatility 124.06%
  • IV Percentile 4%
  • IV Rank 2.19%
  • IV High 651.31% on 03/20/26
  • IV Low 108.46% on 03/06/26
  • Expected Move (DTE 18) 0.29 (12.25%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 253
  • Put/Call OI Ratio 3.26
  • Today's Open Interest 890
  • Open Int (30-Day) 9,848
  • Expected Range 2.07 to 2.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.26
  • Number of Estimates 2
  • High Estimate $-0.26
  • Low Estimate $-0.26
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.65 +43.03%
on 08/03/26
2.59 -8.88%
on 08/26/26
+0.73 (+44.79%)
since 07/31/26
3-Month
1.17 +101.71%
on 07/24/26
2.59 -8.88%
on 08/26/26
+0.71 (+43.03%)
since 05/29/26
52-Week
1.13 +108.85%
on 03/30/26
2.89 -18.34%
on 10/28/25
+0.60 (+34.09%)
since 08/28/25

Most Recent Stories

More News
Pulmonx to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that...

LUNG : 2.36 (-0.84%)
Pulmonx to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that...

LUNG : 2.36 (-0.84%)
Pulmonx Reports Second Quarter 2026 Financial Results

REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.36 (-0.84%)
Pulmonx Reports Second Quarter 2026 Financial Results

REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally...

LUNG : 2.36 (-0.84%)
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments...

LUNG : 2.36 (-0.84%)
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...

LUNG : 2.36 (-0.84%)
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

REDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments...

LUNG : 2.36 (-0.84%)
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

REDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...

LUNG : 2.36 (-0.84%)
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally...

LUNG : 2.36 (-0.84%)
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.36 (-0.84%)

Business Summary

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

See More

Key Turning Points

3rd Resistance Point 2.60
2nd Resistance Point 2.56
1st Resistance Point 2.47
Last Price 2.36
1st Support Level 2.34
2nd Support Level 2.29
3rd Support Level 2.20

See More

52-Week High 2.89
Last Price 2.36
Fibonacci 61.8% 2.22
Fibonacci 50% 2.01
Fibonacci 38.2% 1.80
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.